# Comparative Bioavailability Study of Aripiprazole 10 mg Oral Soluble Film vs Abilify® 10 mg Tablet in Healthy Volunteers

> **NCT02501109** · PHASE1 · COMPLETED · sponsor: **CMG Pharmaceutical Co. Ltd** · enrollment: 36 (actual)

## Conditions studied

- Schizophrenia

## Interventions

- **DRUG:** Aripiprazole

## Key facts

- **NCT ID:** NCT02501109
- **Lead sponsor:** CMG Pharmaceutical Co. Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-10
- **Primary completion:** 2016-02
- **Final completion:** 2016-03
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2016-03-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02501109

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02501109, "Comparative Bioavailability Study of Aripiprazole 10 mg Oral Soluble Film vs Abilify® 10 mg Tablet in Healthy Volunteers". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02501109. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*